UK
On 4 June, the UK Prime Minister will host the Global Vaccine Summit, bringing together leaders from around the world at a virtual event to pledge their support to Gavi, the Vaccine Alliance, to protect a further 300 million children against infectious diseases like measles, typhoid and polio.
The Global Vaccine Summit aims to raise at least US$7.4 billion to help Gavi save up to 8 million lives. As hosts the UK is continuing its global leadership on tackling preventable deaths and stopping the spread of coronavirus.  This builds on our recent role as co-lead for the Global Coronavirus Response Initiative, with Japan, Germany, France, Canada, Norway, Italy, Spain, Saudi Arabia and the European Commission, which successfully raised 7.4 billion euros toward vaccines, tests and treatment to tackle the virus at the Coronavirus Global Response International Pledging Conference on 4 May.
At that conference the UK pledged £388 million which is made up of support we have announced for new vaccines, tests and treatments. This includes:
       £250 million to the Coalition for Epidemic Preparedness Innovations to research a coronavirus vaccine – the biggest contribution of any country to this fund.
       £40 million to support the Global Therapeutics Accelerator, a fund for the rapid development of coronavirus treatments.
       £23 million to support the Foundation for Innovative New Diagnostics to develop rapid tests for the virus to help identify and slow its spread.
       And £75 million for the World Health Organization to help them support countries who have weak healthcare systems.
The UK is collaborating with our international partners on the global effort to find a vaccine as soon as possible and ensure it’s available across the world, including in Nigeria.  We are working closely with industry and the Bioindustry Association to accelerate vaccine development and manufacturing in the UK, so that when a vaccine is available, it can be made quickly at scale. We are now calling on other governments to step up, follow our lead and make commitments to fund fully Gavi’s vital mission for the next five years.
The UK is proud to be Gavi’s leading donor, and on 29 April the International Development Secretary pledged the equivalent of £330 million a year over the next five years from the aid budget to protect 75 million children from preventable diseases. Gavi is a crucial partner in the fight against infectious diseases globally, including coronavirus.  With the support of UK Aid, Gavi has immunised over 760 million children in the world’s poorest countries, saving more than 13 million lives. Between 2000 and 2023 Gavi has committed over 3 billion US dollars alone to Nigeria to combat diseases like Measles, Meningitis and Yellow Fever. This work is essential if we are to avoid further disease outbreaks and epidemics that would result in needless child deaths and place additional strain on health systems already weakened by coronavirus. Gavi is critical to fighting coronavirus too. In the face of the pandemic, and with UK support, Gavi is already helping poorer countries strengthen vulnerable health systems to help deal with the rising number of coronavirus cases, addressing countries’ immediate COVID-19 needs, including essential supplies such as PPE and infection prevention and control.
Speaking on the upcoming Summit, the British High Commissioner to Nigeria, Catriona Laing said:
          
“Producing a vaccine for Covid-19 is a priority for the UK government as this will help save lives in Nigeria and globally from the deadly virus.  Gavi is already working hard with partners to ensure any future vaccine that is safe and effective is delivered at scale around the world.
We welcome Gavi’s partnership with Nigeria over the years, which has helped to fight diseases such as yellow fever, meningitis and measles by improving immunisation rates and strengthening the health systems across the country. 
I welcome the international recognition Nigerians have received for their role in supporting the global effort to find a cure and stop the spread of the coronavirus such as Gavi’s recognition of the Nigerian Public Health and Health Promotion Specialist, Dr. Obinna Ebirim, for his tireless and passionate advocacy for equitable access to vaccines and sustainable immunisation financing in Nigeria.”
Speaking on the upcoming Summit, Dr. Obinna said:
Gavi is known to support health systems strengthening initiatives that ensures that Vaccines get to the last mile where they are used to vaccinate children and prevent vaccine preventable diseases.
“As we move towards the Global Vaccine Summit to be hosted by the United Kingdom, I call on countries and donors to support the work Gavi is doing. Your support to Gavi means that you are supporting Vaccination programmes in poor and remote communities around the world and in Nigeria, that wouldn’t have had access to vaccines if not for the support Gavi provides.
“Remember, one of the things we have learnt from Covid-19 pandemic is that what affects the health of one country affects the health of everyone. Your support to Gavi; to support low and middle income countries is also a support to your country.”
The UK has committed an additional £20m through the African Union’s new ‘Africa anti-COVID 19 fund’ to recruit and deploy African health experts where they are needed most, to tackle the pandemic.
·       Gavi, the Vaccine Alliance was formed in 2000 as a public-private partnership committed to saving children’s lives and protecting people’s health by increasing access to immunisation in developing countries.
·       Gavi provides vaccines, and finances health and immunisation system strengthening in developing countries. It works in partnership with WHO and UNICEF to deliver vaccines in-country.
·       Gavi’s programmes to support routine immunisation in the 68 poorest countries means these countries have healthier populations and stronger health systems. Healthier people are better placed to resist serious illness and stronger health systems are better placed to respond to global outbreaks/pandemics, such as COVID-19.

Leave a Reply

Your email address will not be published. Required fields are marked *